Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引：0
|
作者：
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构：
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    [J]. PHARMACEUTICS, 2023, 15 (05)
  • [32] The impact of retinal fluid tolerance on the outcomes of neovascular age-related macular degeneration treated using aflibercept: A real-world study
    Jeng, Yu-Ting
    Lai, Tso-Ting
    Lin, Chao-Wen
    Chen, Ta-Ching
    Hsieh, Yi-Ting
    Lin, Chang-Ping
    Ho, Tzyy-Chang
    Yang, Chung-May
    Yang, Chang-Hao
    [J]. PLOS ONE, 2022, 17 (07):
  • [33] Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson L.
    Aydogmus, Fatma Sema Akkan
    Lasalle, Claudia C.
    Ramsey, David J.
    [J]. LIFE-BASEL, 2023, 13 (02):
  • [34] Consequences of Real-world Surveillance of Fellow Eyes in Neovascular Age-related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Akkan, F. Sema
    Lasalle, Claudia
    Ramsey, David J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [35] New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
    Patel, Prem
    Sheth, Veeral
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [36] Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD)
    Shah, Parth
    Rafijah, Neala
    Tang, Yannan
    Sivaprasad, Sobha
    Mathis, Thibaud
    Margaron, Philippe
    Kotecha, Aachal
    [J]. BMJ OPEN OPHTHALMOLOGY, 2024, 9 (01):
  • [37] Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
    Aljundi, Wissam
    Munteanu, Cristian
    Seitz, Berthold
    Abdin, Alaa Din
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2867 - 2874
  • [38] Ranibizumab in patients with neovascular age-related macular degeneration: results from the real-world LUMINOUS™ study
    Souied, E.
    Clemens, A.
    Macfadden, W.
    [J]. ACTA OPHTHALMOLOGICA, 2017, 95
  • [39] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Zarbin, Marco A.
    MacCumber, Mathew W.
    Karcher, Helene
    Adiguzel, Eser
    Mayhook, Andrew
    LaPrise, Andrew
    Bilano, Ver L.
    Igwe, Franklin
    Ip, Michael S.
    Wykoff, Charles C.
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1357 - 1368
  • [40] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Marco A. Zarbin
    Mathew W. MacCumber
    Helene Karcher
    Eser Adiguzel
    Andrew Mayhook
    Andrew LaPrise
    Ver L. Bilano
    Franklin Igwe
    Michael S. Ip
    Charles C. Wykoff
    [J]. Ophthalmology and Therapy, 2024, 13 : 1357 - 1368
12345